Keywords: forest, labs, merck, co, deal, pharmaceutical, concern

FOREST LABS IN MERCK & CO DEAL

Article | 03 August 1992

Print This

Forest Labs, the US pharmaceutical concern, has announced its acquisition of the rights to the Du Pont Merck influenza A ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in